SCHEMBL3703248

SCHEMBL3703248

Nc1ccc(F)c(C=O)c1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
TDP1 Q9NUW8 4/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
THRB P10828 2/20 0.38
RECQL P46063 2/20 0.38
NPC1 O15118 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
APEX1 P27695 1/20 0.38
RAB9A P51151 1/20 0.38
BLM P54132 1/20 0.38
MCL1 Q07820 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CA12 O43570 2/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA4 P22748 2/20 0.35
CA6 P23280 2/20 0.35
CA5A P35218 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL488952 0.84 ALDH1A1 (0.42) ALDH1A1TDP1MEN1KMT2AMAPT
SCHEMBL953875 0.80 ALDH1A1 (0.44) ALDH1A1TDP1MEN1KMT2ANPC1
SCHEMBL2891346 0.80 CYP2C9 (0.41) ALDH1A1TDP1MEN1KMT2ACA12
SCHEMBL2730797 0.77 MEN1 (0.37) ALDH1A1TDP1MEN1KMT2ACYP3A4
SCHEMBL2252231 0.77 ERN1 (0.44) ALDH1A1TDP1MEN1KMT2ARAB9A
SCHEMBL23832846 0.77 MEN1 (0.37) ALDH1A1TDP1MEN1KMT2ACYP3A4
SCHEMBL29956992 0.77 ALDH1A1 (0.37) ALDH1A1TDP1MEN1KMT2ARECQL
SCHEMBL828218 0.77 ALDH1A1 (0.37) ALDH1A1TDP1MEN1KMT2ARECQL
SCHEMBL10290089 0.77 CYP3A4 (0.36) ALDH1A1MEN1KMT2ACA12CA1
SCHEMBL19126540 0.76 CA12 (0.36) ALDH1A1TDP1MEN1KMT2ACA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122860-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS PLEXXIKON, INC. 2012-05-17 US disclosed
WO-2010129570-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS PLEXXIKON, INC. (US) 2010-11-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120122860-A1 SOLID FORMS OF SULFONAMIDES AND AMINO ACIDS BRAF, RAF1, ARAF ALDH1A1 3328/4885TDP1 3504/4885MEN1 2348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.